Auron Therapeutics
PrivateLast Round
Series B
Feb 4, 2025
Est. Valuation
$158M
Total Funding Raised
$87.75M
Momentum Score
25 /100
Company Overview
Auron Therapeutics is a biotechnology company dedicated to researching and developing innovative therapies in the fields of immunology and oncology, with a focus on transforming malignant cells into normal functioning cells to advance novel cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Auron Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Auron Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 4, 2025 | ||||
| Series A | Jul 20, 2022 | ||||
| Seed | Jan 27, 2021 |
Auron Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apollo Ventures | Series B, Series A |
| DCVC Bio | Series B, Series A |
| BrightEdge | Series B, Series A, Seed |
| BrightEdge | Series B, Series A |
| Arkin Holdings | Series B, Series A |
| Mubadala Capital | Series B, Series A |
| Qiming | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 13, 2025
Will attend the 8th Annual Targeted Protein Degradation & Induced Proximity Summit.
- Apr 3, 2025
Presented data at the Small Cell Lung Cancer Meeting in New York.
Auron Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Auron Therapeutics's valuation, stock price, and market status.
